LGC Biosearch Technologies A/S: Financial statements 2017
CVR: 34884900
Source: annual report 2017, Danish Business Authority
01/04/2016 – 31/03/2017
LGC Biosearch Technologies A/S (CVR 34884900) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 6,401,663 and a net result of DKK -3,693,954. Equity in the 2017 report amounted to DKK 7,567,522. The solvency ratio was 34.6%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 6,401,663
- Profit/Loss
- DKK -3,693,954
- Equity
- DKK 7,567,522
- Total Assets
- DKK 21,869,435
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 6.4M | -3.7M | 7.6M | 18 |
| 2014 | - | 5.8M | -728K | 14.6M | - |
| 2013 | - | 4.5M | -1.2M | 15.3M | - |
Official annual report
Keep an eye on LGC Biosearch Technologies A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout LGC Biosearch Technologies A/S
LGC Biosearch Technologies A/S is a Danish company of the type Aktieselskab based in Lystrup, founded in 2012. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named DNA TECHNOLOGY A/S and BIOSEARCH TECHNOLOGIES DENMARK A/S. The management consists of Daren Dick. The board consists of Henrik Daugård (chair), Bettina Kecskes and Daren Dick. The company is owned by Biosearch Technologies, Inc.. The company has 47 employees (2026). In 2026, the company reported revenue of DKK 106,677,751 and a net result of DKK 8,198,725 compared with DKK 11,805,577 the year before. Equity in the 2026 report amounted to DKK 88,072,722.